Furthermore, in a single patient harboring the mutant C9ORF72 gene, CSF levels of poly-glycine-proline (poly-GP) DPRs, a stable biomarker of C9ORF72-ALS, were decreased following multiple intrathecal administrations of ASOs [73, 74]. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.